Hemodialysis and Peritoneal Dialysis Market, by Product Type (Device (Machines, Dialyzer, Water Treatment System, and Others) and Consumables), by Procedure (Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis) and Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD)), by End User (Home Care Setting, Hospitals, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

  • To Be Published : Dec 2019 |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Dialysis therapy includes hemodialysis to purify the blood using an artificial kidney (dialyzer) and peritoneal dialysis to purify the blood through one's own peritonea. There are two types of dialysis which are hemodialysis and peritoneal dialysis. Hemodialysis involves purification of the blood by removing waste products and extra fluid with the help of dialyzer membrane and the purified blood is returned into the body. Peritoneal dialysis involves purification of the blood by using the patient's own peritoneum as a dialysis membrane. Patients with chronic kidney diseases are generally kept on dialysis and normal kidney function can only be achieved through kidney transplantation.

Hemodialysis and Peritoneal Dialysis Market Drivers

Global hemodialysis and peritoneal dialysis market growth is expected to be driver by innovative product launches by leading manufacturers, mergers and acquisitions, and initiatives by manufacturers to sustain and compete in global hemodialysis and peritoneal dialysis market. For instance, leading manufacturers such as Fresenius Medical Care AG & Co. KGaA are focusing on product launches as well as merger and acquisitions. Fresenius Medical Care supported the recommendation by the National Institute for Health and Care Excellence (NICE) to facilitate population healthcare management for UK patients with end-stage renal disease by using hemodiafiltration (HDF) rather than high-flux hemodialysis (HD) in October 2018. This is expected to boost global hemodialysis and peritoneal dialysis market growth over the forecast period.

Moreover, Fresenius Medical Care and Humacyte, Inc. entered into a strategic partnership in November 2018. Humacyte has developed HUMACYL, which is currently being investigated for vascular access for hemodialysis. Moreover, in April 2018, Fresenius Medical Care won the Red Dot Award: Product Design for the company’s 6008 CAREset bloodline system used in hemodialysis. Furthermore, Fresenius Medical Care signed an agreement to acquire NxStage Medical, Inc., (NxStage), a U.S.-based medical technology and Services Company in 2017. B. Braun Medical, Inc. signed an agreement to acquire the bloodlines business operated under the Medisystems name by NxStage Medical, Inc. In 2017 NxStage Medical, Inc. announced that the U.S. Food and Drug Administration (FDA) cleared its System One for solo home hemodialysis. These factors are expected to support global hemodialysis and peritoneal dialysis market growth over the forecast period.

Stringent regulatory policies for the approval and manufacturing, reimbursement, and risks and complications associated with dialysis treatment are expected to restrain global hemodialysis and peritoneal dialysis market growth over the forecast period.

Hemodialysis and Peritoneal Dialysis Market Regional Analysis

North America hemodialysis and peritoneal dialysis market is expected to hold dominant position in the global market over the forecast period. Presence of leading manufacturers as well as increasing number of dialysis procedures is expected to support global hemodialysis and peritoneal dialysis market growth. According to National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), over 661,000 people in the U.S. had kidney failure and of these, 468,000 individuals were on dialysis, 2017. These factors have supported the North America hemodialysis and peritoneal dialysis market growth.

Hemodialysis and Peritoneal Dialysis Market Key Players

Key players operating in the global hemodialysis and peritoneal dialysis market include Fresenius Medical Care AG & Co. KGaA, DaVita Healthcare Partners, Inc., Baxter International, Inc., B. Braun Melsungen AG, Nipro Corporation, Diaverum Deutschland GmbH, Nikkiso Co. Ltd., Asahi Kasei Corporation, and NxStage Medical, Inc.

Hemodialysis and Peritoneal Dialysis Market Taxonomy:

The global hemodialysis and peritoneal dialysis market is segmented on the basis of product type, application, end user, and region

By Product Type:

  • Device
    • Machines
    • Dialyzer
    • Water Treatment System
    • Others
  • Consumables

By Procedure:

  • Hemodialysis
    • Conventional Hemodialysis
    • Short Daily Hemodialysis
    • Nocturnal Hemodialysis
  • Peritoneal Dialysis
    • Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • Automated Peritoneal Dialysis (APD)

By End User:

  • Home Care Setting
  • Hospitals
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.